Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM BSE: 507789

₹168.67

(0.01%)

Wed, 04 Mar 2026, 05:44 am

MTF 5xInvest in Jagsonpal Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap11.3B

PE Ratio27.54

Dividend1.48

Health Technology

Pharmaceuticals: Generic

24.5K

Jagsonpal Pharmaceuticals Enterprise Value (EV)

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	30.30	15.79	13.33	3.29	5.51	5.72	4.49	14.44	12.64	63.33	26.41	8.41	0	9.55	5.81	12.22	43.57	28.42	33.04	26.26
Price to book ratio	1.13	0.61	0.54	0.25	0.58	0.44	0.34	0.27	0.27	0.78	0.87	0.91	0.72	0.66	0.41	1.71	6.19	4.78	3.95	5.98
Price to sales ratio	0.51	0.34	0.27	0.15	0.37	0.25	0.19	0.16	0.19	0.54	0.60	0.69	0.56	0.41	0.29	1.11	3.78	3.21	3.56	5.41
Price to cash flow ratio	50.05	18.70	2.97	0.99	59.58	6.35	12.30	3.86	12.56	0	22.93	0	0	2.29	3.38	6.93	100.50	15.21	17.46	23.06
Enterprise value	1.18B	901.15M	749.63M	412.21M	655.99M	622.94M	585.2M	495.5M	501.8M	992.49M	1.09B	876.83M	642.61M	341.52M	123.06M	1.53B	7.75B	6.51B	6.03B	13.35B
Enterprise value to EBITDA ratio	8.70	8.29	5.95	2.73	4.17	4.29	3.52	4.92	4.70	11.37	9.21	14.35	0	3.66	1.43	8.01	29.63	18.40	25.46	25.82
Debt to equity ratio	0.60	0.68	0.54	0.35	0.23	0.31	0.35	0.34	0.36	0.41	0.39	0.07	0.08	0.04	0.06	0.06	0	0.04	0.05	0.04
Return on equity %	0	3.93	4.17	7.95	11.02	7.96	7.79	1.86	2.15	1.21	3.36	11.39	-11.11	7.13	7.30	14.64	14.81	18.44	12.97	25.91

Jagsonpal Pharmaceuticals Ltd Enterprise Value

The Jagsonpal Pharmaceuticals Ltd Enterprise Value is a key financial metric used by investors to evaluate Jagsonpal Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Jagsonpal Pharmaceuticals Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM, BSE: 507789) is currently trading at ₹168.67, with a market capitalization of ₹11.3B. As a leading company in the Health technology sector and Pharmaceuticals: generic industry, monitoring the Jagsonpal Pharmaceuticals Ltd Enterprise Value is essential for fundamental analysis.

Jagsonpal Pharmaceuticals Ltd Enterprise Value Current Value

The current Jagsonpal Pharmaceuticals Ltd Enterprise Value stands at 13.35B.

The latest Jagsonpal Pharmaceuticals Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Jagsonpal Pharmaceuticals Ltd Enterprise Value Historical Trend

The Jagsonpal Pharmaceuticals Ltd Enterprise Value has shown the following historical trend:

2024: 13.35B
2023: 6.03B
2022: 6.51B
2021: 7.75B
2020: 1.53B

The recent rise in Jagsonpal Pharmaceuticals Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What Jagsonpal Pharmaceuticals Ltd Enterprise Value Indicates for Investors

The Jagsonpal Pharmaceuticals Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd Enterprise Value Analysis Summary

The Jagsonpal Pharmaceuticals Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Jagsonpal Pharmaceuticals Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Jagsonpal Pharmaceuticals Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800